Catalyst Wire Dossier Catalyst Wire Dossier

Fengliao Changweikang

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fengliao Changweikang, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial [Phase 4]

See pricing